Tenet Healthcare Corporation (NYSE:THC) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Tenet Healthcare Corporation (NYSE:THC) have received a consensus recommendation of “Moderate Buy” from the twenty-two brokerages that are presently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $244.1579.

A number of equities research analysts recently weighed in on the company. Robert W. Baird dropped their price objective on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Royal Bank Of Canada dropped their price objective on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. Mizuho increased their price target on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research note on Thursday, March 12th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Tenet Healthcare in a research note on Friday, March 27th. Finally, Guggenheim decreased their price target on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a research note on Friday, May 1st.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 3,000 shares of the stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director directly owned 24,805 shares in the company, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the transaction, the executive vice president directly owned 29,291 shares in the company, valued at $6,983,853.13. This represents a 18.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 23,138 shares of company stock valued at $4,976,589. 0.97% of the stock is owned by corporate insiders.

Institutional Trading of Tenet Healthcare

Several institutional investors have recently bought and sold shares of the business. Wedmont Private Capital grew its holdings in Tenet Healthcare by 2.5% in the fourth quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock valued at $422,000 after purchasing an additional 50 shares during the period. Baron Wealth Management LLC lifted its position in Tenet Healthcare by 4.8% during the fourth quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock worth $227,000 after buying an additional 52 shares in the last quarter. PeakShares LLC lifted its position in Tenet Healthcare by 3.3% during the first quarter. PeakShares LLC now owns 1,693 shares of the company’s stock worth $319,000 after buying an additional 54 shares in the last quarter. Sagespring Wealth Partners LLC lifted its position in Tenet Healthcare by 3.6% during the fourth quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock worth $313,000 after buying an additional 55 shares in the last quarter. Finally, Sanctuary Advisors LLC lifted its position in Tenet Healthcare by 0.5% during the first quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock worth $2,246,000 after buying an additional 57 shares in the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Price Performance

Shares of THC stock opened at $164.28 on Wednesday. Tenet Healthcare has a twelve month low of $146.60 and a twelve month high of $247.21. The stock has a market capitalization of $14.15 billion, a price-to-earnings ratio of 8.54, a P/E/G ratio of 1.12 and a beta of 1.28. The stock has a fifty day simple moving average of $189.23 and a two-hundred day simple moving average of $201.72. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same period in the prior year, the business earned $4.36 EPS. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, analysts predict that Tenet Healthcare will post 17.67 EPS for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.